+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

PRINTER FRIENDLY

Cell Therapy Technologies Market by Product (Consumables, Equipment, Software), Cell Type (Human Stem & Differentiated, Animal), Process Stages (Cell Processing, Distribution, Handling, QC), End User, and Region - Global Forecast to 2023

  • ID: 4721419
  • Report
  • Region: Global
  • 117 Pages
  • Markets and Markets
1 of 5
The Global Cell Therapy Instruments Market is Projected to Reach USD 19.9 Billion by 2023 from USD 10.2 Billion in 2018, at a CAGR of 14.4%

FEATURED COMPANIES

  • Ge Healthcare
  • Lonza Group
  • Merck KGaA
  • Miltenyi Biotec GmbH
  • Sartorius
  • Stemcell Technologies
  • MORE

Global cell therapy instruments market to register a CAGR of 14.4% from 2018 to 2023

The global cell therapy instruments market is projected to reach USD 19.9 billion by 2023 from USD 10.2 billion in 2018, at a CAGR of 14.4% during the forecast period. Factors such as rising government investments for cell-based research, the increasing number of GMP-certified production facilities, and the large number of oncology-oriented cell-based therapy clinical trials are driving the growth of this market. However, the high cost of cell-based research and low success rate are expected to restrain market growth during the forecast period.

Consumables segment to account for the largest market share in 2018

Based on the product, the cell therapy instruments market is segmented into consumables, equipment, and systems & software. In 2018, the consumables segment is expected to account for the largest share of the cell therapy instruments market. Factors such as increasing investments by companies to develop advanced products as well as government initiatives for enhancing cell-based research are contributing to the growth of the cell therapy consumables market.

Cell processing segment dominates the cell therapy instruments market during the forecast period

Based on process, the cell therapy instruments market is segmented into cell processing; cell preservation, distribution, and handling; and process monitoring and quality control. The cell processing segment is expected to account for the largest share of the market in 2018 and is expected to grow at the highest CAGR during the forecasted period. The cell processing stage makes the highest use of cell therapy instruments and media, especially during culture media processing. This is the major factor responsible for the large share and high growth of this segment.

Human cells to register the highest growth during the forecast period

Based on cell type, the cell therapy instruments market is segmented into human cells and animal cells. In 2018, the human cells segment is expected to account for the largest share of the cell therapy instruments market. The rising adoption of human cells over animal cells for cell therapeutics research, technological advancements, and the rising incidence of diseases such as cancer and cardiac abnormalities are the key factors driving the growth of this segment.

North America to command the largest share of the cell therapy instruments market in 2018

The cell therapy instruments market is segmented into four major regions, namely, North America, Europe, Asia Pacific, and the Rest of the World (RoW). North America is expected to account for the largest market share in 2018. The increasing R&D activities in the pharmaceutical and biotechnology industries is one of the major factors driving the demand for cell therapy instruments in North America during the forecast period.

Breakdown of supply-side primary interviews, by company type, designation, and region:

  • By Company Type: Tier 1 - 20%, Tier 2 - 45%, and Tier 3 - 35%
  • By Designation: C-level - 30%, Director-level - 20%, and Others - 50%
  • By Region: North America - 35%, Europe - 24%, Asia Pacific - 25%, and the RoW - 16%

Major players in this market include Beckman Coulter (US), Becton, Dickinson and Company (US), GE Healthcare (US), Lonza (Switzerland), Merck KGaA (Germany), Miltenyi Biotec (Germany), STEMCELL Technologies, Inc. (Canada), Terumo BCT (US), and Thermo Fisher Scientific (US).

Research Coverage:
This report studies the cell therapy instruments market based on product, cells type, process, end user, and region. The report also analyzes factors (such as drivers, opportunities, and restraints) affecting market growth. It evaluates opportunities and challenges in the market for stakeholders and provides details of the competitive landscape for market leaders. The report also studies micromarkets with respect to their growth trends, prospects, and contributions to the total cell therapy instruments market. The report forecasts the revenue of the market segments with respect to four major regions.

Reasons to Buy the Report
The report provides insights on the following pointers:

  • Market Penetration: Comprehensive information on cell therapy instruments offered by the top 10 players in the global cell therapy instruments market. The report analyzes the cell therapy instruments market by product, cell type, end user, process stage, and region
  • Market Development: Comprehensive information about lucrative emerging markets. The report analyzes the markets for various cell therapy instruments across key regions
  • Market Diversification: Exhaustive information about new products, untapped geographies, recent developments, and investments in the global cell therapy instruments market
  • Competitive Assessment: In-depth assessment of market shares, strategies, products, and recent developments of the leading players in the global cell therapy instruments market
Note: Product cover images may vary from those shown
2 of 5

FEATURED COMPANIES

  • Ge Healthcare
  • Lonza Group
  • Merck KGaA
  • Miltenyi Biotec GmbH
  • Sartorius
  • Stemcell Technologies
  • MORE

1 Introduction
1.1 Objectives of the Study
1.2 Market Definition
1.2.1 Markets Covered
1.2.2 Years Considered for the Study
1.3 Currency
1.4 Limitations
1.5 Stakeholders

2 Research Methodology
2.1 Research Data
2.1.1 Secondary Data
2.1.1.1 Key Data From Secondary Sources
2.1.2 Primary Data
2.1.2.1 Key Data From Primary Sources
2.2 Market Size Estimation
2.2.1 Bottom-Up Approach
2.2.2 Top-Down Approach
2.3 Market Breakdown and Data Triangulation
2.4 Assumptions for the Study

3 Executive Summary

4 Premium Insights
4.1 Cell Therapy Instruments: Market Overview
4.2 Cell Therapy Instruments Market, By Product & Cell Types (2018)
4.3 Geographical Snapshot of the Cell Therapy Instruments Market

5 Market Overview
5.1 Introduction
5.2 Market Dynamics
5.2.1 Drivers
5.2.1.1 Rising Government Investments in Cell-Based Research
5.2.1.2 Large Number of Oncology-Oriented Cell-Based Therapy Clinical Trials
5.2.1.3 Affordability and Sustainability of Advanced Cell Therapy Instruments
5.2.2 Restraints
5.2.2.1 High Cost of Cell-Based Research and Low Success Rate
5.2.3 Opportunities
5.2.3.1 Emerging Countries

6 Cell Therapy Instruments Market, By Product
6.1 Introduction
6.2 Consumables
6.2.1 Consumables Segment to Account for the Largest Share of the Cell Therapy Instruments Market During the Forecast Period
6.3 Equipment
6.3.1 Cell Processing Equipment
6.3.1.1 Cell Processing Equipment are Essential in Laboratories and Institutes for Conducting Research
6.3.2 Single-Use Equipment
6.3.2.1 Technological Advancements & the Increasing Demand for Biological Products to Drive Market Growth
6.3.3 Other Equipment
6.4 Systems & Software
6.4.1 Cell Therapy Systems & Software are Used to Monitor the Different Stages of Cell Processing

7 Cell Therapy Instruments Market, By Process
7.1 Introduction
7.2 Cell Processing
7.2.1 Cell Processing Makes the Highest Use of Cell Therapy Instruments, Which is A Major Growth Driver of This Segment
7.3 Cell Preservation, Distribution, and Handling
7.3.1 Demand Growth for Cell-Based Medical Products and Therapies to Drive the Market for Reliable Storage Equipment
7.4 Process Monitoring and Quality Control
7.4.1 Process Monitoring is Essential to Ensure the Quality and Accuracy of Cell Processing

8 Cell Therapy Instruments Market, By Cell Type
8.1 Introduction
8.2 Human Cells
8.2.1 Stem Cells
8.2.1.1 Investments From Venture Capitalists for Stem Cell Research are A Major Factor Driving the Growth of This Market
8.2.2 Differentiated Cells
8.2.2.1 Increasing Investments From Market Players to Develop New and Innovative Products is A Key Factor Driving Market Growth
8.3 Animal Cells
8.3.1 Growing Investments in Animal Cell Research is A Major Factor Driving the Growth of This Market

9 Cell Therapy Instruments Market, By End User
9.1 Introduction
9.2 Life Science Research Companies
9.2.1 Increasing Number of Cell-Based Experiments and Drug Discovery Activities to Drive Market Growth
9.3 Research Institutes
9.3.1 Growing Research Activities Supporting the Growth of This End-User Segment

10 Cell Therapy Instruments Market, By Region
10.1 Introduction
10.2 North America
10.2.1 Us
10.2.1.1 US Will Continue to Dominate the North American Cell Therapy Instruments Market During the Forecast Period
10.2.2 Canada
10.2.2.1 High Burden of Chronic Diseases to Drive the Adoption of Cell Therapy Instruments in Canada
10.3 Europe
10.3.1 Germany
10.3.1.1 Germany to Be the Fastest-Growing Market for Cell Therapy Instruments in Europe
10.3.2 Uk
10.3.2.1 Rising Prevalence of Ncds in the UK to Drive Market Growth
10.3.3 Rest of Europe
10.4 Asia Pacific
10.4.1 China
10.4.1.1 Increasing Cell Therapy-Based Research to Support Market Growth in China
10.4.2 Japan
10.4.2.1 Increasing Geriatric Population and Subsequent Growth in the Disease Burden to Support Market Growth in Japan
10.4.3 Rest of Asia Pacific
10.5 Rest of the World

11 Competitive Landscape
11.1 Overview
11.2 Market Players Ranking Analysis, 2017
11.2.1 Top Players in the Cell Therapy Instruments Market
11.3 Competitive Scenario

12 Company Profiles
12.1 Thermo Fisher Scientific, Inc.
12.2 Merck KGaA
12.3 Terumo Bct, Inc. (A Subsidiary of Terumo Corporation)
12.4 Lonza Group
12.5 Ge Healthcare
12.6 Sartorius
12.7 Becton, Dickinson and Company
12.8 Beckman Coulter, Inc. (Subsidiary of Danaher Corporation)
12.9 Miltenyi Biotec GmbH
12.10 Stemcell Technologies

13 Appendix
13.1 Insights From Industry Experts
13.2 Discussion Guide
13.3 Knowledge Store: Subscription Portal
13.4 Available Customizations
13.5 Related Reports
13.6 Author Details

List of Tables
Table 1 National Institutes of Health (NIH) Funding in the Us, 2013-2016 (USD Million)
Table 2 Breakdown of Current Active Cell Therapy Clinical Trials By Cell Group and Trial Phase
Table 3 Cell Therapy Instruments Market, By Product, 2016–2023 (USD Million)
Table 4 Cell Therapy Consumables Market, By Region, 2016–2023 (USD Million)
Table 5 Cell Therapy Equipment Market, By Region, 2016–2023 (USD Million)
Table 6 Cell Therapy Equipment Market, By Type, 2016–2023 (USD Million)
Table 7 Cell Processing Equipment Market, By Region, 2016–2023 (USD Million)
Table 8 Single-Use Equipment Market, By Region, 2016–2023 (USD Million)
Table 9 Cell Therapy Market for Other Equipment, By Region, 2016–2023 (USD Million)
Table 10 Cell Therapy Systems & Software Market, By Region, 2016–2023 (USD Million)
Table 11 Cell Therapy Instruments Market, By Process, 2016–2023 (USD Million)
Table 12 Cell Therapy Instruments Market for Cell Processing, By Region, 2016–2023 (USD Million)
Table 13 Cell Therapy Instruments Market for Cell Preservation, Distribution, and Handling, By Region, 2016–2023 (USD Million)
Table 14 Cell Therapy Instruments Market for Process Monitoring and Quality Control, By Region, 2016–2023 (USD Million)
Table 15 Cell Therapy Instruments Market, By Cell Type, 2016–2023 (USD Million)
Table 16 Cell Therapy Instruments Market for Human Cells, By Region, 2016–2023 (USD Million)
Table 17 Cell Therapy Instruments Market for Human Cells, By Cell Type, 2016–2023 (USD Million)
Table 18 Cell Therapy Instruments Market for Stem Cells, By Region, 2016–2023 (USD Million)
Table 19 Cell Therapy Instruments Market for Differentiated Cells, By Region, 2016–2023 (USD Million)
Table 20 Cell Therapy Instruments Market for Animal Cells, By Region, 2016–2023 (USD Million)
Table 21 Cell Therapy Instruments Market, By End User, 2016–2023 (USD Million)
Table 22 Cell Therapy Instruments Market for Life Science Research Companies, By Region, 2016–2023 (USD Million)
Table 23 Cell Therapy Instruments Market for Research Institutes, By Region, 2016–2023 (USD Million)
Table 24 Cell Therapy Instruments Market, By Region, 2016–2023 (USD Million)
Table 25 North America: Cell Therapy Instruments Market, By Country, 2016–2023 (USD Million)
Table 26 North America: Cell Therapy Instruments Market, By Product, 2016–2023 (USD Million)
Table 27 North America: Cell Therapy Instruments Market, By Process, 2016–2023 (USD Million)
Table 28 North America: Cell Therapy Instruments Market, By Cell Type, 2016–2023 (USD Million)
Table 29 North America: Cell Therapy Instruments Market, By End User, 2016–2023 (USD Million)
Table 30 US: Cell Therapy Instruments Market, By Product, 2016–2023 (USD Million)
Table 31 US: Cell Therapy Instruments Market, By Process, 2016–2023 (USD Million)
Table 32 US: Cell Therapy Instruments Market, By Cell Type, 2016–2023 (USD Million)
Table 33 US: Cell Therapy Instruments Market, By End User, 2016–2023 (USD Million)
Table 34 Canada: Cell Therapy Instruments Market, By Product, 2016–2023 (USD Million)
Table 35 Canada: Cell Therapy Instruments Market, By Process, 2016–2023 (USD Million)
Table 36 Canada: Cell Therapy Instruments Market, By Cell Type, 2016–2023 (USD Million)
Table 37 Canada: Cell Therapy Instruments Market, By End User, 2016–2023 (USD Million)
Table 38 Europe: Cell Therapy Instruments Market, By Country, 2016–2023 (USD Million)
Table 39 Europe: Cell Therapy Instruments Market, By Product, 2016–2023 (USD Million)
Table 40 Europe: Cell Therapy Instruments Market, By Process, 2016–2023 (USD Million)
Table 41 Europe: Cell Therapy Instruments Market, By Cell Type, 2016–2023 (USD Million)
Table 42 Europe: Cell Therapy Instruments Market, By End User, 2016–2023 (USD Million)
Table 43 Germany: Cell Therapy Instruments Market, By Product, 2016–2023 (USD Million)
Table 44 Germany: Cell Therapy Instruments Market, By Process, 2016–2023 (USD Million)
Table 45 Germany: Cell Therapy Instruments Market, By Cell Type, 2016–2023 (USD Million)
Table 46 Germany: Cell Therapy Instruments Market, By End User, 2016–2023 (USD Million)
Table 47 UK: Cell Therapy Instruments Market, By Product, 2016–2023 (USD Million)
Table 48 UK: Cell Therapy Instruments Market, By Process, 2016–2023 (USD Million)
Table 49 UK: Cell Therapy Instruments Market, By Cell Type, 2016–2023 (USD Million)
Table 50 UK: Cell Therapy Instruments Market, By End User, 2016–2023 (USD Million)
Table 51 RoE: Cell Therapy Instruments Market, By Product, 2016–2023 (USD Million)
Table 52 RoE: Cell Therapy Instruments Market, By Process, 2016–2023 (USD Million)
Table 53 RoE: Cell Therapy Instruments Market, By Cell Type, 2016–2023 (USD Million)
Table 54 RoE: Cell Therapy Instruments Market, By End User, 2016–2023 (USD Million)
Table 55 Asia Pacific: Cell Therapy Instruments Market, By Country, 2016–2023 (USD Million)
Table 56 Asia Pacific: Cell Therapy Instruments Market, By Product, 2016–2023 (USD Million)
Table 57 Asia Pacific: Cell Therapy Instruments Market, By Process, 2016–2023 (USD Million)
Table 58 Asia Pacific: Cell Therapy Instruments Market, By Cell Type, 2016–2023 (USD Million)
Table 59 Asia Pacific: Cell Therapy Instruments Market, By End User, 2016–2023 (USD Million)
Table 60 China: Cell Therapy Instruments Market, By Product, 2016–2023 (USD Million)
Table 61 China: Cell Therapy Instruments Market, By Process, 2016–2023 (USD Million)
Table 62 China: Cell Therapy Instruments Market, By Cell Type, 2016–2023 (USD Million)
Table 63 China: Cell Therapy Instruments Market, By End User, 2016–2023 (USD Million)
Table 64 Japan: Cell Therapy Instruments Market, By Product, 2016–2023 (USD Million)
Table 65 Japan: Cell Therapy Instruments Market, By Process, 2016–2023 (USD Million)
Table 66 Japan: Cell Therapy Instruments Market, By Cell Type, 2016–2023 (USD Million)
Table 67 Japan: Cell Therapy Instruments Market, By End User, 2016–2023 (USD Million)
Table 68 RoAPAC: Cell Therapy Instruments Market, By Product, 2016–2023 (USD Million)
Table 69 RoAPAC: Cell Therapy Instruments Market, By Process, 2016–2023 (USD Million)
Table 70 RoAPAC: Cell Therapy Instruments Market, By Cell Type, 2016–2023 (USD Million)
Table 71 RoAPAC: Cell Therapy Instruments Market, By End User, 2016–2023 (USD Million)
Table 72 RoW: Cell Therapy Instruments Market, By Product, 2016–2023 (USD Million)
Table 73 RoW: Cell Therapy Instruments Market, By Process, 2016–2023 (USD Million)
Table 74 RoW: Cell Therapy Instruments Market, By Cell Type, 2016–2023 (USD Million)
Table 75 RoW: Cell Therapy Instruments Market, By End User, 2016–2023 (USD Million)

List of Figures
Figure 1 Research Design
Figure 2 Breakdown of Primary Interviews: By Company Type, Designation, and Region
Figure 3 Cell Therapy Instruments Market: Bottom-Up Approach
Figure 4 Cell Therapy Instruments Market: Top-Down Approach
Figure 5 Data Triangulation Methodology
Figure 6 Cell Therapy Instruments Market, By Product, 2018 vs 2023 (USD Million)
Figure 7 Cell Therapy Instruments Market, By Cell Type, 2018 vs 2023 (USD Million)
Figure 8 Cell Therapy Instruments Market, By Process, 2018 vs 2023 (USD Million)
Figure 9 Cell Therapy Instruments Market, By End User, 2018 vs 2023 (USD Million)
Figure 10 Cell Therapy Instruments Market, By Region, 2018 vs 2023 (USD Million)
Figure 11 Rising Government Investment for Cell-Based Research to Drive Market Growth During the Forecast Period
Figure 12 Consumables and Human Cells to Dominate the Cell Therapy Instruments Market in 2018
Figure 13 Countries in Asia to Register A Higher Growth Rate During the Forecast Period
Figure 14 Cell Therapy Instruments Market: Drivers, Restraints, and Opportunities
Figure 15 Cell Therapy Consumables to Witness the Highest Growth During the Forecast Period (2018–2023)
Figure 16 Cell Processing Segment to Witness the Highest Growth During the Forecast Period
Figure 17 Human Cells to Witness the Highest Growth in the Cell Therapy Instruments Market During the Forecast Period
Figure 18 Life Science Research Companies to Be the Largest End-User Segment in the Cell Therapy Instruments Market
Figure 19 Asia Pacific to Witness the Highest Growth in the Cell Therapy Instruments Market During the Forecast Period
Figure 20 North America: Cell Therapy Instruments Market Snapshot
Figure 21 Asia Pacific: Cell Therapy Instruments Market Snapshot
Figure 22 Key Developments in the Cell Therapy Instruments Market From 2015 to 2018
Figure 23 Thermo Fisher Scientific: Company Snapshot
Figure 24 Merck KGaA: Company Snapshot
Figure 25 Terumo Corporation: Company Snapshot
Figure 26 Lonza Group: Company Snapshot
Figure 27 GE Healthcare: Company Snapshot
Figure 28 Sartorius: Company Snapshot
Figure 29 Becton, Dickinson and Company: Company Snapshot
Figure 30 Danaher Corporation: Company Snapshot

Note: Product cover images may vary from those shown
3 of 5

Loading
LOADING...

4 of 5
5 of 5
  • Beckman Coulter, Inc. (Subsidiary of Danaher Corporation)
  • Becton, Dickinson and Company
  • Ge Healthcare
  • Lonza Group
  • Merck KGaA
  • Miltenyi Biotec GmbH
  • Sartorius
  • Stemcell Technologies
  • Terumo Bct, Inc. (A Subsidiary of Terumo Corporation)
  • Thermo Fisher Scientific, Inc.
Note: Product cover images may vary from those shown
Adroll
adroll